Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HH.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HH.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HH.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HH.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HH.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.85EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.85ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.85ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.85EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.85EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.85ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.85ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GB.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GB.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GB.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GB.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GB.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.72EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.72ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.72ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.72EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.72EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used